A New Testosterone Gel (Fortesta) for Hypogonadism
Date: April 18, 2011 Issue #: 1362 Summary: The FDA has approved Fortesta (Endo), a topical gel, for testosterone replacement therapy in adult males with hypogonadism. It is classified as a Schedule...
View ArticleA Long-Acting Depot Formulation of Testosterone (Aveed)
Date: March 31, 2014 Issue #: 1439 Summary: The FDA has approved testosterone undecanoate (Aveed– Endo), an injectable depot formulation, for use in men with hypogonadism who require testosterone...
View ArticleTestosterone Nasal Gel (Natesto) for Hypogonadism
Date: May 11, 2015 Issue #: 1468 Summary: The FDA has approved an intranasal gel formulation of testosterone (Natesto– Trimel/Endo) for replacement therapy in men with hypogonadism. Packaged in a...
View ArticleSafety of Testosterone Replacement Therapy
Date: March 14, 2016 Issue #: 1490 Summary: Three coordinated double-blind, placebo-controlled clinical trials have evaluated the efficacy of one year of testosterone replacement therapy in improving...
View Article